Artigos com autorizações de acesso público - Mary CushmanSaiba mais
26 artigos não disponíveis publicamente
Revisar
Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA)
SD Weiner, HN Ahmed, Z Jin, M Cushman, DM Herrington, JC Nelson, ...
Heart 100 (11), 862-866, 2014
Autorizações: US National Institutes of Health
Revisar
Interaction between fibrinogen and IL‐6 genetic variants and associations with cardiovascular disease risk in the cardiovascular health study
CL Carty, P Heagerty, SR Heckbert, GP Jarvik, LA Lange, M Cushman, ...
Annals of human genetics 74 (1), 1-10, 2010
Autorizações: US National Institutes of Health
Revisar
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.
Lp-PLA2 Studies Collaboration
European Journal of Preventive Cardiology 14 (1), 3-11, 2007
Autorizações: British Heart Foundation
Revisar
Measures to assess the prognostic ability of the stratified Cox proportional hazards model
Fibrinogen Studies Collaboration
Statistics in Medicine 28 (3), 389-411, 2009
Autorizações: British Heart Foundation
Revisar
The prognostic value of interleukin 6 in multiple chronic diseases and all-cause death: The Multi-Ethnic Study of Atherosclerosis (MESA)
M Cainzos-Achirica, C Enjuanes, P Greenland, JW McEvoy, M Cushman, ...
Atherosclerosis 278, 217-225, 2018
Autorizações: US National Institutes of Health
Revisar
Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers
MC Chu, M Cushman, R Solomon, RA Lobo
American journal of obstetrics and gynecology 199 (5), 526. e1-526. e7, 2008
Autorizações: US National Institutes of Health
Revisar
Inflammation and descending thoracic aortic calcification as detected by computed tomography: the Multi-Ethnic Study of Atherosclerosis
J Takasu, R Katz, DM Shavelle, K O’Brien, SS Mao, JJ Carr, M Cushman, ...
Atherosclerosis 199 (1), 201-206, 2008
Autorizações: US National Institutes of Health
Revisar
Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial)
HN Hodis, JAS John, M Xiang, M Cushman, RA Lobo, WJ Mack
The American journal of cardiology 101 (8), 1131-1133, 2008
Autorizações: US National Institutes of Health
Revisar
Development of a clinical prediction rule for venous thromboembolism in patients with acute leukemia
F Al-Ani, YP Wang, A Lazo-Langner
Thrombosis and haemostasis 120 (02), 322-328, 2020
Autorizações: Canadian Institutes of Health Research
Revisar
Inflammation and peripheral venous disease
M Cushman, PW Callas, MA Allison, MH Criqui
Thrombosis and haemostasis 112 (09), 566-572, 2014
Autorizações: US National Institutes of Health
Revisar
Prevention of venous thromboembolism in hospitalized medically ill patients: a US perspective
AC Spyropoulos, W Ageno, AT Cohen, CM Gibson, SZ Goldhaber, ...
Thrombosis and Haemostasis 120 (06), 924-936, 2020
Autorizações: US National Institutes of Health
Revisar
Inflammation biomarkers and incident coronary heart disease: the reasons for geographic and racial differences in stroke study
OP Akinyelure, LD Colantonio, NS Chaudhary, BC Jaeger, SE Judd, ...
American Heart Journal 253, 39-47, 2022
Autorizações: US National Institutes of Health, American Heart Association
Revisar
Unraveling the influence of common von Willebrand factor variants on von Willebrand disease phenotype: an exploratory study on the molecular and clinical profile of von …
N Borràs, I Garcia-Martínez, J Batlle, A Pérez-Rodríguez, R Parra, ...
Thrombosis and Haemostasis 120 (03), 437-448, 2020
Autorizações: Government of Spain
Revisar
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
AH Talasaz, P Sadeghipour, L Ortega-Paz, H Kakavand, ...
Nature Reviews Cardiology 21 (8), 574-592, 2024
Autorizações: European Commission
Revisar
Plasma Biomarkers of Kidney Health and Mortality in Diabetes and Chronic Kidney Disease in the REGARDS Study.
TK Chen, MM Estrella, R Katz, MJ Sarnak, ME Grams, M Cushman, ...
Clinical Journal of the American Society of Nephrology, 10.2215, 2024
Autorizações: US National Institutes of Health
Revisar
Continuous cardiac rhythm monitoring post-stroke: A feasibility study in REGARDS
NVK Pothineni, EZ Soliman, M Cushman, G Howard, VJ Howard, ...
Journal of Stroke and Cerebrovascular Diseases 31 (11), 106662, 2022
Autorizações: US National Institutes of Health
Revisar
On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for …
L Wahid, JD Froess, TL Ortel, R Zarychanski, JS Berger, M Cushman, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 45 (1), 162-164, 2025
Autorizações: Fonds de recherche du Québec - Santé
Revisar
Risk Factors for Bleeding after Recent Medical Hospitalization: The Medical Inpatient Thrombosis and Hemostasis Study (MITH)
M Gergi, K Wilkinson, A Sparks, NS Roetker, H Al-Samkari, NL Smith, ...
Blood 144, 2252, 2024
Autorizações: National Institute for Health Research, UK
Revisar
Plasma Biomarkers and Mortality Among REGARDS Participants with Diabetes and CKD: TH-PO173
TK Chen, MM Estrella, R Katz, MJ Sarnak, M Grams, M Cushman, ...
Journal of the American Society of Nephrology 34 (11S), 137, 2023
Autorizações: US National Institutes of Health
Revisar
Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
RM Tanner, N Chaudary, LD Colantonio, TR Merriman, RJ Reynolds, ...
Journal of Hypertension 41 (6), 1033-1039, 2023
Autorizações: US National Institutes of Health
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador